CD14 and neoplasm: Eight other immune subsets, including naive CD4+ T cells, Lag-3+/−CD8+ T cells and CD14+macrophages, showed no significant enrichment in neither tumour groups (Supplementary Fig. 8a), although CD27− B cells with unknown functions were also significantly enriched in tumours with low immune-ITH (Fig. 3a).